Skip to main content

Advertisement

Table 1 Resistance rates of S. aureus isolates in nine European countries - adults 18+

From: Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureusin the community

    Resistance rates(%)(95%confidence interval)
Country Swabs Isolates ofS. aureus Azithromycin Clindamycin Erythromycin Oxacillin Penicillin Fucidic acid Mupirocin
Austria 3168 522 (16.5%) 12.8** (6.3-19.4) 11.1 (4.9 - 17.3) 12.6** (6.1-19.1) 1.5 (0-3.9) 64.4 (55-73.8) 1.0 (0-3.0) 0.2 (0-1.1)
Belgium 2892 552 (19.1%) 16.3 (9.1-23.5) 14.4 (7.5-21.3) 16.3 (9.1-23.5) 2.2 (0-5.1) 72.5 (63.7-81.3) 3.4 (0-7.0) 0.4 (0-1.6)
Croatia 3380 601 (17.8%) 5.8 (1.2-10.4) 5.5 (1-10) 5.8 (1.2-10.4) 2.3 (0-5.2) 75.4** (67-83.8) 0.2 (0-1.1) 0.7 (0-2.3)
France 3536 777 (22.0%) 17.5 (10.1-25.0) 14.9* (7.9-21.9) 17.1 (9.7-24.5) 1.8 (0-4.4) 74.4 (65.8-83) 4.0 (0.2-7.8) 0.1 (0-0.7)
Hungary 2883 359 (12.5%) 10.3** (4.3-16.3) 10.3** (4.3-16.3) 10.3** (4.3-16.3) 1.9 (0-4.6) 71.0** (62.1-79.9) 0.3 (0-1.4) 0.3 (0-1.4)
NL 3491 947 (27.1%) 6.9 (1.9-11.9) 5.2 (0.8-9.6) 5.5 (1.0-10.0) 1.0 (0-3.0) 68.4 (59.3-77.5) 5.2 (0.8-9.6) 0
Spain 3563 620 (17.5%) 11.5 (5.3-17.8) 9.5 (3.8-15.2) 11.0 (4.9-17.1) 1.3 (0-3.5) 86.0* (79.2-92.8) 1.1 (0-3.1) 1.6 (0-4.1)
Sweden 2859 846 (29.6%) 1.3 (0-3.5) 11.8 (5.5-18.1) 13.0 (6.4-19.6) 0 64.3* (54.9-73.7) 1.9 (0-4.6) 0
UK 3152 811 (25.7%) 8.6 (3.1-14.1) 7.5 (2.3-12.7) 8.9 (3.3-14.5) 1.6 (0-4.1) 73.4 (64.7-82.1) 7.8 (2.5-13.1) 0
  1. **Significant difference with children under p < 0.05.
  2. *Significant difference with children under p < 0.1.